Hasil Pencarian - John J. Alam
- Menampilkan 1 - 7 hasil dari 7
-
1
Correction: Drug development targeting degeneration of the basal forebrain cholinergic system: its time has come oleh John J. Alam, Ralph A. Nixon
Diterbitkan 2023-11-01
Artikel -
2
Drug development targeting degeneration of the basal forebrain cholinergic system: its time has come oleh John J. Alam, Ralph A. Nixon
Diterbitkan 2023-10-01
Artikel -
3
P38α MAPK Signaling—A Robust Therapeutic Target for Rab5-Mediated Neurodegenerative Disease oleh Ursula A. Germann, John J. Alam
Diterbitkan 2020-07-01
Artikel -
4
Continuous administration of a p38α inhibitor during the subacute phase after transient ischemia-induced stroke in the rat promotes dose-dependent functional recovery accompanied b... oleh John J Alam, Michael Krakovsky, Ursula Germann, Aharon Levy
Diterbitkan 2020-01-01
Artikel -
5
-
6
A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer’s disease oleh Niels D. Prins, John E. Harrison, Hui-May Chu, Kelly Blackburn, John J. Alam, Philip Scheltens, for the REVERSE-SD Study Investigators
Diterbitkan 2021-05-01
Artikel -
7
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration oleh Ying Jiang, John J. Alam, Stephen N. Gomperts, Paul Maruff, Afina W. Lemstra, Ursula A. Germann, Philip H. Stavrides, Sandipkumar Darji, Sandeep Malampati, James Peddy, Cynthia Bleiwas, Monika Pawlik, Anna Pensalfini, Dun-Sheng Yang, Shivakumar Subbanna, Balapal S. Basavarajappa, John F. Smiley, Amanda Gardner, Kelly Blackburn, Hui-May Chu, Niels D. Prins, Charlotte E. Teunissen, John E. Harrison, Philip Scheltens, Ralph A. Nixon
Diterbitkan 2022-09-01
Artikel